Abstract
Maximal resection is the first treatment to propose in DLGG, since allowing a delay of malignant transformation with a significant increase of overall survival. The use of intraoperative mapping enabled a minimization of the postsurgical morbidity while increasing the extent of resection. On the basis of these new concepts of “functional neurooncological surgery,” the future step will be to evolve toward a “preventive neurosurgery” in incidentally discovered DLGG. Indeed, because of the development of noninvasive MRI, one can observe an increased number of incidental DLGG (IDLGG) for unrelated complaints (e.g., headaches, traumatic brain injury) or research studies. In the current literature, the incidence of IDLGG ranges from 0.025 to 0.3 %, and its prevalence is evaluated about 0.05–0.2 % in the healthy population.
The natural history of IDLGG was recently analyzed, showing that it was not a benign tumor, but an entity that will grow in all cases (with a growth rate very close to that of symptomatic DLGG), and with a risk of malignant transformation ultimately leading to the death. Thus, because IDLGG likely represents an earlier step in the natural course of a glioma than the symptomatic DLGG, their behavior supports the idea that they should be managed as symptomatic DLGG. In this state of mind, several authors proposed to achieve surgical removal of DLGG diagnosed in asymptomatic patients. The rate of total and supratotal resections was improved in comparison with surgical series of symptomatic DLGG, while the rate of permanent deficit was very low, even in critical areas. Interestingly, microfoci with endothelial proliferation were identified in the middle of the tumor in around a quarter of the cases, demonstrating that beginning of malignant transformation may occur before any symptoms. Therefore, these data plead in favor of an early surgical treatment in asymptomatic patients, to maximize the extent of resection before glioma growth and migration, even in eloquent regions. In summary, the similarity of the natural course of DLGG during the silent and symptomatic periods supports “prophylactic” surgical resection of IDLGG.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Soffietti R, Baumert B, Bello L, von Deimling A, Duffau H, Frenay M, et al. Guidelines on management of low grade gliomas: report of an EFNS-EANO task force. Eur J Neurol. 2010;17:1124–33.
Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, et al. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol. 2008;26:1338–45.
Capelle L, Fontaine D, Mandonnet E, Taillandier L, Golmard JL, Bauchet L, et al. Spontaneous and therapeutic prognostic factors in adult hemispheric WHO grade II gliomas: a series of 1097 cases. J Neurosurg. (in press).
Duffau H. Surgery of low-grade gliomas: towards a “functional neurooncology”. Curr Opin Oncol. 2009; 21:543–9.
de Witt Hamer PC, Gil Robles S, Zwinderman A, Duffau H, Berger MS. Impact of intraoperative stimulation brain mapping on glioma surgery outcome: a meta-analysis. J Clin Oncol. 2012;30(20):2559–65.
Duffau H, Lopes M, Arthuis F, Bitar A, Sichez JP, van Effenterre R, et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985–96) and with (1996–2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76:845–51.
Duffau H. A new concept of diffuse (low-grade) glioma surgery. Adv Tech Stand Neurosurg. 2012;38:3–27.
Duffau H. The challenge to remove diffuse low grade gliomas while preserving brain functions. Acta Neurochir (Wien). 2012;154:569–74.
Yordanova Y, Moritz-Gasser S, Duffau H. Awake surgery for WHO grade II gliomas within “noneloquent” areas in the left dominant hemisphere: toward a “supratotal” resection. J Neurosurg. 2011;115:232–9.
Eskandary H, Sabba M, Khajehpour F, Eskandari M. Incidental findings in brain computed tomography scans of 3000 head trauma patients. Surg Neurol. 2005;63:550–3.
Onizuka M, Suyama K, Shibayama A, Hiura T, Horie N, Miyazaki H. Asymptomatic brain tumor detected at brain check-up. Neurol Med Chir (Tokyo). 2011;41:431–4.
Weber F, Knopf H. Incidental findings in magnetic resonance imaging of the brains of healthy young men. J Neurol Sci. 2006;240:81–4.
Yue NC, Longstreth Jr WT, Elster AD, Jungreis CA, O’Leary DH, Poirier VC. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the Cardiovascular Health Study. Radiology. 1997;202:41–6.
Katzman GL, Dagher AP, Patronas NJ. Incidental findings on brain magnetic resonance imaging from 1000 asymptomatic volunteers. JAMA. 1999;282:36–9.
Morris Z, Whiteley WN, Longstreth Jr WT, Weber F, Lee YC, Tsushima Y, et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357:1821–8.
Bauchet L, Rigau V, Mathieu-Daude H, Figarella-Branger D, Hugues D, Palusseau L, et al. French brain tumor data bank: methodology and first results on 10,000 cases. J Neurooncol. 2007;84:189–99.
Olson JD, Riedel E, DeAngelis LM. Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology. 2000;54:1442–8.
Kamiguchi H, Shiobara R, Toya S. Accidentally detected brain tumors: clinical analysis of a series of 110 patients. Clin Neurol Neurosurg. 1996;98:171–5.
Pallud J, Fontaine D, Duffau H, Mandonnet E, Sanai N, Taillandier L, et al. Natural history of incidental World Health Organization grade II gliomas. Ann Neurol. 2010;68:727–33.
Potts MB, Smith JS, Molinaro AM, Berger MS. Natural history and surgical management of incidentally discovered low-grade gliomas. J Neurosurg. 2012;116:326–72.
Duffau H. Awake surgery for incidental WHO grade II gliomas involving eloquent areas. Acta Neurochir. 2012;154:757–84.
Duffau H, Gatignol P, Mandonnet E, Capelle L, Taillandier L. Contribution of intraoperative subcortical stimulation mapping of language pathways: a consecutive series of 115 patients operated on for a WHO grade II glioma in the left dominant hemisphere. J Neurosurg. 2008;109:461–71.
Gil Robles S, Duffau H. Surgical management of World Health Organization Grade II gliomas in eloquent areas: the necessity of preserving a margin around functional structures. Neurosurg Focus. 2010;28:E8.
Kelly PJ. Gliomas: survival, origin and early detection. Surg Neurol Int. 2010;1:96.
Klein M, Duffau H, De Witt Hamer PC. Cognition and resective surgery for diffuse infiltrative glioma: an overview. J Neurooncol. 2012;108:309–18.
Pallud J, Taillandier L, Capelle L, Fontaine D, Peyre M, Ducray F, et al. Quantitative morphological MRI follow-up of low-grade glioma: a plead for systematic measurement of growth rates. Neurosurgery. 2012;71(3):729–39.
Duffau H, Pallud J, Mandonnet E. Evidence for the genesis of WHO grade II glioma in an asymptomatic young adult using repeated MRIs. Acta Neurochir (Wien). 2011;153:473–7.
Gerin C, Pallud J, Grammaticos B, Mandonnet E, Deroulers C, Varlet P, et al. Improving the time-machine: estimating date of birth of grade II gliomas. Cell Prolif. 2012;45:76–90.
Gozé C, Rigau V, Gibert L, Maudelonde T, Duffau H. Lack of complete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: the marker of worse prognosis? J Neurooncol. 2009;91:1–5.
Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, Crinière E, Capelle L, Duffau H, et al. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology. 2004;63:2360–2.
Vergani F, Martino J, Gozé C, Rigau V, Duffau H. WHO grade II gliomas and subventricular zone: anatomical, genetic and clinical considerations. Neurosurgery. 2011;68:1293–9.
Duffau H. The rationale to perform early resection in incidental diffuse low-grade glioma: toward a “preventive surgical neurooncology”. World Neurosurg. (in press).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Duffau, H. (2013). Early Detection and Management of Incidental Diffuse Low-Grade Gliomas (IDLGG): Toward a “Prophylactic Oncological Neurosurgery”. In: Duffau, H. (eds) Diffuse Low-Grade Gliomas in Adults. Springer, London. https://doi.org/10.1007/978-1-4471-2213-5_31
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2213-5_31
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2212-8
Online ISBN: 978-1-4471-2213-5
eBook Packages: MedicineMedicine (R0)